Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.

Antimicrobial agents and chemotherapy - 1 Mar 2011

Costa-de-Oliveira Sofia, Marcos Miranda Isabel, Silva Raquel M, Pinto E Silva Ana, Rocha Rita, Amorim António, Gonçalves Rodrigues Acácio, Pina-Vaz Cidália

Abstract excerpt

This is the first case report of Candida glabrata-disseminated candidiasis describing the acquisition of echinocandin resistance following anidulafungin treatment. The initial isolates recovered were susceptible to echinocandins. However, during 27 days of anidulafungin treatment, two resistant strains were isolated (from the blood and peritoneal fluid). The resistant peritoneal fluid isolate exhibited a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antifungal Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Candida glabrata

Share to Candidiasis

Share to Drug Resistance, Fungal

Share to Echinocandins

Share to Glucosyltransferases

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 21149621
DOI: 10.1128/AAC.00589-10
PMCID: PMC3067100

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.PMID 21149621Read ↗

Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure.Semantic proximity Read ↗

Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata.Semantic proximity Read ↗

Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.Semantic proximity Read ↗

Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolatesSemantic proximity Read ↗

Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular CharacterizationSemantic proximity Read ↗

FKS1 mutation associated with decreased echinocandin susceptibility of Aspergillus fumigatus following anidulafungin exposure.Semantic proximity Read ↗

Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China.Semantic proximity Read ↗

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.Semantic proximity Read ↗

Recurrent episodes of candidemia due to Candida glabrata with a mutation in hot spot 1 of the FKS2 gene developed after prolonged therapy with caspofungin.Semantic proximity Read ↗

Positions and numbers of FKS mutations in Candida albicans selectively influence in vitro and in vivo susceptibilities to echinocandin treatment.Semantic proximity Read ↗

Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial Candida glabrata isolates.Semantic proximity Read ↗

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.